|
Bryomixol is a great scientific development and a significant advancement in the area of supplemental and preventive treatment of cancer.
Clinical testing conducted in vitro, on experimental animals, and on human volunteers has demonstrated the effectiveness of the Bryomixol treatment, as a re-energizer of physical and mental performance, with powerful immunomodulating and immunostimulating characteristic. |
Bryomixol formulas were
developed in post-war Germany and then taken to
South America, where, since the 1980's, it has
been used extensively in human medicine.
Hundreds of cancer patients have been treated
with this medication in South America, with
excellent results.
Certain researchers in the
United States have become interested in
determining the precise therapeutic value of
this new medications, which are capable of
curtailing the advance of cancer, without any
toxic effect to the patient.